德琪医药-B9月16日斥资19.77万港元回购2.95万股
ANTENGENEANTENGENE(HK:06996) Zhi Tong Cai Jing·2025-09-16 11:51

Core Viewpoint - 德琪医药-B (06996) announced a share buyback of 29,500 shares at a cost of HKD 197,700 on September 16, 2025 [1] Group 1 - The company is engaging in a share repurchase program, indicating confidence in its own stock value [1] - The total expenditure for the buyback is approximately HKD 197,700, which reflects the company's strategy to enhance shareholder value [1] - The number of shares being repurchased is 29,500, which may impact the stock's liquidity and market perception [1]